Argatroban therapy in patients with hepatic and renal impairment

被引：7

作者：

Brand, P. -A. ^{[1
]}

Scholz, J. ^{[1
]}

Weller, N. ^{[1
]}

Bein, B. ^{[1
]}

Egberts, J. -H. ^{[2
]}

机构：

[1] Univ Hosp Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, D-24105 Kiel, Germany

[2] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany

来源：

EUROPEAN JOURNAL OF ANAESTHESIOLOGY | 2008年 / 25卷 / 04期

关键词：

D O I：

10.1017/S0265021507002839

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：344 / 346

页数：3

共 7 条

[1] Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD [J].

Dager, WE ;

White, RH .

ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) :1232-1236

[2] Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer [J].

Kubiak, DW ;

Szumita, PM ;

Fanikos, JR .

ANNALS OF PHARMACOTHERAPY, 2005, 39 (06) :1119-1123

[3] Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor [J].

LaMonte, Marian P. ;

Brown, Philip M. ;

Hursting, Marcie J. .

EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (01) :31-41

[4] A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease [J].

Murray, PT ;

Reddy, BV ;

Grossman, EJ ;

Hammes, MS ;

Trevino, S ;

Ferrell, J ;

Tang, I ;

Hursting, MJ ;

Shamp, TR ;

Swan, SK .

KIDNEY INTERNATIONAL, 2004, 66 (06) :2446-2453

[5] Excessive argatroban anticoagulation for heparin-induced thrombocytopenia [J].

Reichert, MG ;

MacGregor, DA ;

Kincaid, EH ;

Dolinski, SY .

ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) :652-654

[6] The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction [J].

Swan, SK ;

Hursting, MJ .

PHARMACOTHERAPY, 2000, 20 (03) :318-329

[7] Successful recovery after an overdose of argatroban [J].

Yee, AJ ;

Kuter, DJ .

ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) :336-339

← 1 →